Esti Handayani Hardi1, Rudy Agung Nugroho2, Irawan Wijaya Kusuma3, Wiwin Suwinarti3, Agung Sudaryono4, Rita Rostika5. 1. Microbiology Laboratory, Department of Aquaculture, Faculty of Fisheries and Marine Science, Mulawarman University, Samarinda, East Kalimantan, 75123, Indonesia. 2. Animal Physiology, Development and Molecular Laboratory, Department of Biology, Faculty of Mathematics and Natural Sciences, Mulawarman University, Samarinda, East Kalimantan, 75123, Indonesia. 3. Laboratory of Forest Product Chemistry, Faculty of Forestry, Mulawarman University, Samarinda, East Kalimantan, 75123, Indonesia. 4. Department of Aquaculture, Faculty of Fisheries and Marine Science, Diponegoro University, Semarang, Central Java, 50275, Indonesia. 5. Department of Fisheries, Faculty of Fisheries and Marine Science, Padjajaran University, Bandung, West Java, 40600, Indonesia.
Abstract
Background: The combination of some plant extracts to prevent and treat bacterial infections is gaining momentum, because of effectiveness against certain bacteria. This study aims to describe the antibacterial and immunostimulant abilities of Boesenbergia pandurata (BP), Solanum ferox (SF) and Zingiber Zerumbet (ZZ) plant extracts to treat and prevent Aeromonas hydrophila and Pseudomonas fluorescens infection on Tilapia ( Oreochromis niloticus). Methods: Tilapia (initial weight 15±2 g) were injected intramuscularly (0.1 ml/fish) with a combination of A. hydrophila and P. fluorescens at a density of 1×10 5 CFU ml -1 of each bacteria. Treatment trials were performed at day 7 post-injection with each combined extract, while the prevention trial was performed by including the combined extract into the commercial diet for six and seven days prior to injection. Various extract combinations were 60 mg SF extract/kg feed with 40 mg ZZ/kg feed (SF60/ZZ40), SF50/ZZ50, BP90/SF10, and BP50/SF50. Haemato-immunological parameters were performed for four weeks. Results: In prevention trials, tilapia fed SF50/ZZ50 showed a significant increase of white and red blood cells. Similarly, significantly increased haematocrit was found in tilapia fed SF50/ZZ50 in the treatment trial but not in the prevention trial. In both trials, haemoglobin of tilapia was not affected by any combined extracts but decreased the number of bacteria. Phagocytic index, respiratory burst, lysozyme activity and survival rate of fish fed combined extracts were found significantly higher than controls. The amount of pathogenic bacteria in fish fed combined extracts was lower than the control at week 4 ( P<0.05). In both trials The percentage of survival rate and relative percent survival of tilapia fed SF 50/ZZ 50, showed the optimum results compared to the other combinations. Conclusions: The combined extract in feed, especially SF50/ZZ50 has a positive effect on the tilapia's innate immune system of tilapia to treat and prevent bacterial infections.
Background: The combination of some plant extracts to prevent and treat bacterial infections is gaining momentum, because of effectiveness against certain bacteria. This study aims to describe the antibacterial and immunostimulant abilities of Boesenbergia pandurata (BP), Solanum ferox (SF) and Zingiber Zerumbet (ZZ) plant extracts to treat and prevent Aeromonas hydrophila and Pseudomonas fluorescensinfection on Tilapia ( Oreochromis niloticus). Methods: Tilapia (initial weight 15±2 g) were injected intramuscularly (0.1 ml/fish) with a combination of A. hydrophila and P. fluorescens at a density of 1×10 5 CFU ml -1 of each bacteria. Treatment trials were performed at day 7 post-injection with each combined extract, while the prevention trial was performed by including the combined extract into the commercial diet for six and seven days prior to injection. Various extract combinations were 60 mg SF extract/kg feed with 40 mg ZZ/kg feed (SF60/ZZ40), SF50/ZZ50, BP90/SF10, and BP50/SF50. Haemato-immunological parameters were performed for four weeks. Results: In prevention trials, tilapia fed SF50/ZZ50 showed a significant increase of white and red blood cells. Similarly, significantly increased haematocrit was found in tilapia fed SF50/ZZ50 in the treatment trial but not in the prevention trial. In both trials, haemoglobin of tilapia was not affected by any combined extracts but decreased the number of bacteria. Phagocytic index, respiratory burst, lysozyme activity and survival rate of fish fed combined extracts were found significantly higher than controls. The amount of pathogenic bacteria in fish fed combined extracts was lower than the control at week 4 ( P<0.05). In both trials The percentage of survival rate and relative percent survival of tilapia fed SF 50/ZZ 50, showed the optimum results compared to the other combinations. Conclusions: The combined extract in feed, especially SF50/ZZ50 has a positive effect on the tilapia's innate immune system of tilapia to treat and prevent bacterial infections.
Tilapia (
Oreochromis niloticus) is one of the most widely cultivated fish species in Indonesia. Tilapia is a freshwater fish that can be easily cultivated
[1]. According to Pridgeon
[2] and Harikrishnan
et al.
[3], freshwater fish culture is inseparable from bacterial infections which are caused by motile
Aeromonas septicaemia, furunculosis, edwardsiellosis and
Aeromonas hydrophila. Further,
Aeromonas species have been identified as major causative bacteria and a serious pathogen in fish
[4,
5]. In Indonesia, particularly East Kalimantan, infection of
A. hydrophila and
Pseudomonas fluorescens in fish results in high mortality rates of up to 60–80%. In fish, both of these bacteria cause stresses, exophthalmia, ulcers, and watery-looking organs, particularly gallbladder rupture
[6–
8]. In addition, combined bacterial infection in fish is also common, such as infections found in tilapia caused by
Salmonella agalactiae and
A. hydrophila
[9,
10].To reduce high mortalities of cultured fish, aquaculturists and researchers use antibiotics to prevent and treat infection. Nevertheless, due to concerns for maintaining eco-friendly environments, the application of antibiotics should be avoided, because they may enhance antibiotic-resistant pathogens, increase the accumulation of drugs in fish tissue and trigger immunosuppression
[11]. Methods of controlling these infections should be developed as soon as possible because the pathogen disease type has significantly increased
[12], while the type of pathogen that leads to edema in the cultivation area still cannot be overcome. One of the effective and safe methods for disease control in aquaculture is by improving the defence system of the fish through the provision of natural immunostimulants
[13], through the use of several plant extracts.Recently, the popularity of plant extracts as natural immunostimulant is gaining in demand and importance in medical purposes. Various plant extracts, such as Indian almond leaves (
Terminalia catappa), oats (
Avena sativa), oyster mushroom (
Pleurotus ostreatus), nettle (
Urtica dioica), sea grass (
Cymodocea serrulata) and beetroot (
Beta vulgaris) have been used as alternatives to antibiotics
[5,
14–
16]. Plant extracts also contain levamisole
[13] and saponin
[17] which can enhance the work of nonspecific immune systems and increase the activation of phagocytosis
[14]. Plant extracts could optimize the fish blood function, by enhancing the number of white blood cell to prevent the bacteria
[5]. Further, the plant extracts of
Boesenbergia pandurata (BP) and
Zingiber zerumbet (ZZ) from East Kalimantan have
in vitro and
in vivo antibacterial activity against
A. hydrophila bacteria, while
Solanum ferox (SF) has been found to be an antibacterial agent for
P. fluorescens bacteria. Similarly, for the prevention and treatment of bacterial infections in tilapia, BP and ZZ are also effective for treating
A. hydrophila and
P. fluorescensinfection
[8,
18].The incorporation of some extracts for the prevention and treatment of bacterial infections is likely to increase the effectiveness because some materials can work synergistically, so that the infection of both bacteria in the fish body can be controlled optimally. However, research regarding the combination of plant extracts to treat and prevent bacterial infection is limited. This study therefore aims to determine the effectiveness of the combination of three extracts (BP, ZZ and SF) to prevent and treat bacterial infections of
A. hydrophila and
P. fluorescens in tilapia.
Methods
Fish and bacteria
In total, 450 Tilapias (Initial weight 15 ± 2 g, age ±2.5 months, random sex) were obtained from Teluk Dalam Village in Tenggarong Seberang, Kutai Kartanegara, Indonesia. The fish were randomly distributed and assigned into five aquariums in triplicates, representing four treatments and one control. The fish were kept in the laboratory for two weeks for acclimatization in the aquarium (60×40×30 cm). Each aquarium was filled with 60 l of freshwater and the water was changed by as much as 50% every 2 days to remove remaining faeces and inedible feed. The average temperature of the water was 27°C. The feed given in the acclimation phase was a commercial feed (PT Rama Jaya Mahakam, Kutai Kartanegara East Kalimantan-Supplier, floating pellets, containing 31–33% protein and 4–6% fat) at a rate of 5% of the body weight of the fish per day. The bacteria used for the challenge test were
A. hydrophila (EA-01) and
P. fluorescens (EP-01), which was provided from the Aquatic Microbiology Laboratory, Faculty of Fisheries and Marine Sciences, Mulawarman University, Indonesia. To bring about bacterial challenge, a combination of bacteria at density of 10
5 CFU ml
-1 of each bacteria was used. Each fish was injected intramuscularly with 0.1 ml of the suspension of the bacteria.
Plant and chemical materials
The plant materials, BP, SF and ZZ, were collected from a traditional market in Samarinda City, East Kalimantan, Indonesia. The plants were cleaned, cut and dried at 40°C for 48 hours in the oven, finely powdered and stored at -4°C for the further extraction stage. Ethanol solution (95%) was used to extract the plant materials, following a method described by Limsuwan & Voravuthikunchai
[19]. All chemicals used in this research was obtained from commercial sources (Sigma Aldrich, Inc. USA).
Experimental design and challenge test
This treatment and prevention trials were carried out for 28 days. The treatment experiments were conducted with five combination treatments with the following stages: tilapia (average initial weight 15 ± 2 g, n = 30 fish per group, random sex) were injected intramuscularly (0.1 ml) with a mixture of
A. hydrophila and
P. fluorescens bacteria, each bacteria at density10
5 CFU ml
-1. At day 7 after injection, the fish were fed with feed combined with extract as follows (mg per kg feed): P1, 60 mg SF extract/kg feed with 40 mg ZZ extract/kg feed (SF60/ZZ40); P2, SF50/ZZ50; P3, BP90/SF10; P4, BP50/SF50; and P5, fed with no additional extract (control). All fish were fed twice a day
ad satiation. The remaining feed was siphoned out before the next feeding.Meanwhile, the prevention trial was performed by providing the same feeding combination and procedure for 6 days prior to intramuscular injection of the fish with 0.1 ml of mixed bacteria at day 7. After injection, feeding combination was continued until the 4
th week. Haematological and immunological parameters were measured every week after the injection with bacteria until week 4.
Haematology and phagocytic index
At days 14, 21 and 28 following bacterial challenge, haematological profiles of fish (n=3 per treatment group) were observed. Fish were anesthetized using 50 mg l
-1 MS 222 (Sigma Aldrich, USA) / dm
3 water. The fish blood was taken through the caudal vein, using a 1 ml syringe rinsed with 10% trisodium citrate anticoagulant (fish were kept alive after blood withdrawal). Total red blood cells (RBC) (10
6 per mm
3) and white blood cells (WBC) (10
3 / mm
3) were determined manually using an improved Neubauer counting chamber. The number of WBC was calculated using the method of Blaxhall and Daisley
[20]. Haemoglobin (Hb) was measured spectrophotometrically at 540 nm using the cyanmethemoglobin method
[17]. The haematocrit (Htc %) was counted using the microcentrifuge and heparinized was used as a standard solution. Meanwhile, phagocytic index was determined using a modification of previous methods by adding Turk solution into suspension of fish blood and bacteria to remove red blood cells. Thus, the number of white blood cells can be easily counted
[20–
22].
Respiratory burst and lysozyme activity
Respiratory burst activity test was performed using nitro blue tetrazolium (NBT) reagent, using the method outlined by Secombes and Olivier
[23]. Meanwhile, lysozyme activity was performed using a microtiter plate ELISA reader at wavelength of 520 nm, following the method described by Soltani and Pourgholam
[24].
Total Plate Count
To perform the total plate count (TPC), a blood sample of each fish from each group was homogenized and diluted in physiological saline solution of 0.85%. The dilutions were then transferred to bacterial counts. The TPC was conducted following the method of Turkogfu
et al.
[25].
Disease resistance
Both
A. hydrophila and
P. fluorescens (the pathogenic bacteria) were used for challenge testing (n = 10 fish per aquarium, in triplicates per group). The survival rate (SR) and relative percent survival (RPS) of the fish were recorded on a daily basis for 4 weeks
[26].
Statistical analysis
Results are expressed as means ± standard error (SE) and the data were analysed using SPSS version 22 (SPSS, Inc., USA). The data of WBC, RBC, haematocrit, Hb, TPC, phagocytic index, respiratory burst and lysozyme activity were subjected to ANOVA, followed by Duncan’s post hoc test to evaluate significant differences among the groups of treatments. The percentage of fish survival were arcsine-transformed. All tests were significant at
P < 0.05.
Results
Haematological profile
The present results revealed that the total WBC count of tilapia in the treatment and prevention trials were significantly increased (
P<0.05) from weeks 2–4 post-administration with combined extracts. The highest increase of WBC was found in tilapia fed with SF50/ZZ50. Similarly, total RBC and haematocrit of tilapia fed SF50/ZZ50 in the treatment trial showed a significant increase after week 2, while tilapia fed SF60/ZZ40 in the prevention trial led to a positively enhanced result from weeks 2–4. Further, haemoglobin of fish both in treatment and prevention trials were not affected by any various combination of extracts (
Table 1).
Table 1.
Hematological profile of Tilapia (
Oreochromis niloticus) fed different extract combination in treatment and prevention trials.
Variables
Trials
groups
Weeks
2
4
WBC
(10
4 cell/mm
3)
Treatment
A
1.68±0.1
[a]
2.07±0.2
[b]
B
3.60±0.1
[b]
8.85±0.2
[c]
C
1.88±0.5
[a]
2.10±0.1
[a]
D
1.98±0.5
[a]
2.20±0.1
[b]
E
1.35±0.2
[a]
1.34±0.1
[a]
Prevention
A
1.85±0.15
[a]
2.4±0.5
[b]
B
3.9±0.2
[b]
7.96±0.2
[c]
C
2.0±0.2
[a]
2.4±0.3
[b]
D
2.0±0.3
[a]
2.5±0.1
[b]
E
1.4±0.5
[a]
1.3±0.1
[a]
RBC
(10
6cell/mm
3)
Treatment
A
5.4±0.3
[a]
4,2±0.1
[b]
B
7.7±0.2
[b]
8.8±0.2
[c]
C
6.3±0.1
[b]
7,2±0.2
[a]
D
6.8±0.2
[a]
7.0±0.1
[b]
E
2.7±0.1
[a]
2.7±0.1
[a]
Prevention
A
6.42±0.25
[a]
6.0±0.5
[b]
B
6.97±0.3
[a]
7.0±0.2
[a]
C
6.23±0.1
[a]
5.53±0.2
[a]
D
5.67±0.1
[a]
7.0±0.1
[a]
E
2.7±0.2
[a]
2.47±0.1
[a]
Hematocrit (%)
Treatment
A
27±0.1
[a]
34±0.1
[b]
B
27±0.2
[b]
36±0.2
[c]
C
27±0.2
[a]
31±0.2
[a]
D
27±0.2
[a]
30±0.2
[a]
E
15±0.3
[a]
15±0.2
[a]
Prevention
A
27±0.1
[a]
27.7±0.1
[a]
B
27±0.2
[a]
34±0.1
[a]
C
27±0.1
[a]
31.5±0.1
[a]
D
27±0.1
[a]
30±0.2
[a]
E
14.7±0.2
[a]
15±0.1
[a]
Hemoglobin
(g dL
-1)
Treatment
A
10±0.3
[a]
10±0.1
[a]
B
10±0.3
[a]
10±0.1
[a]
C
10±0.2
[a]
10±0.1
[a]
D
8±0.2
[a]
10±0.1
[a]
E
8±0.1
[a]
6±0.2
[a]
Prevention
A
10±0.1
[a]
8±0.2
[a]
B
10±0.1
[a]
10±0.1
[a]
C
10±0.1
[a]
8.3±0.1
[a]
D
8±0.1
[a]
8±0.2
[a]
E
8±0.1
[a]
4±0.1
[a]
Note: Mean±standard deviation followed by different superscript letters (a,b,c) in the same column in each variable and each treatment or prevention trial showed significantly different at
P<0.05. WBC = White blood cell, RBC = Red blood cell, A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg per kg feed. BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment and prevention trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence.
Note: Mean±standard deviation followed by different superscript letters (a,b,c) in the same column in each variable and each treatment or prevention trial showed significantly different at
P<0.05. WBC = White blood cell, RBC = Red blood cell, A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg per kg feed. BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment and prevention trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence.
Phagocytic index
All combination extracts fed to fish in the treatment (
Figure 1) and prevention (
Figure 2) trials increased the phagocytic index. The phagocytic index of fish fed SF50/ZZ50 in the diet, in both in treatment and prevention trials, were significantly higher than control and increased from the 2
nd to 4
th week of the post-challenge test.
Figure 1.
Phagocytic index (%) of Tilapia (
Oreochromis niloticus) fed different extract combination in treatment trials.
BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. Infected fish fed various combination and ratio of extract, namely: A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg kg
-1 feed. * = significantly different between week. Different letter above the bars in each week showed significantly different at
P<0.05.
Figure 2.
Phagocytic index (%) of Tilapia (
Oreochromis niloticus) fed different extract combination in prevention trials.
BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. Infected fish fed various combination and ratio of extract, namely: A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition.. Extract ratio is in mg kg
-1 feed. * = significantly different between week. Different letter above the bars in each week showed significantly different at
P<0.05.
Phagocytic index (%) of Tilapia (
Oreochromis niloticus) fed different extract combination in treatment trials.
BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. Infected fish fed various combination and ratio of extract, namely: A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg kg
-1 feed. * = significantly different between week. Different letter above the bars in each week showed significantly different at
P<0.05.
Phagocytic index (%) of Tilapia (
Oreochromis niloticus) fed different extract combination in prevention trials.
BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. Infected fish fed various combination and ratio of extract, namely: A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition.. Extract ratio is in mg kg
-1 feed. * = significantly different between week. Different letter above the bars in each week showed significantly different at
P<0.05.
Respiratory burst
The respiratory burst activity of infected fish fed with combination extract increased from week 2 to week 4 in the treatment trial (
Figure 3). In addition, SF50/ZZ50 (mg per kg feed) combination extract resulted in a significantly different respiratory burst to other combinations of extracts and the control. Meanwhile, in the prevention test, infected fish fed SF50/ZZ50 combination extract in week 4 were significantly higher than control and other combinations of extracts (
P<0.05) (
Figure 4).
Figure 3.
Respiratory burst activity of Tilapia (
Oreochromis niloticus) fed different extract combination in treatment trials.
BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. Infected fish fed various combination and ratio of extract, namely: A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg kg
-1 feed. * = significantly different between week. Different letter above the bars in each week showed significantly different at
P<0.05.
Figure 4.
Respiratory burst activity of Tilapia (
Oreochromis niloticus) fed different extract combination in prevention trials.
BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. Infected fish fed various combination and ratio of extract, namely: A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg kg
-1 feed. * = significantly different between week. Different letter above the bars in each week showed significantly different at
P<0.05.
Respiratory burst activity of Tilapia (
Oreochromis niloticus) fed different extract combination in treatment trials.
BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. Infected fish fed various combination and ratio of extract, namely: A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg kg
-1 feed. * = significantly different between week. Different letter above the bars in each week showed significantly different at
P<0.05.
Respiratory burst activity of Tilapia (
Oreochromis niloticus) fed different extract combination in prevention trials.
BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. Infected fish fed various combination and ratio of extract, namely: A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg kg
-1 feed. * = significantly different between week. Different letter above the bars in each week showed significantly different at
P<0.05.
Lysozyme activity
This study revealed that lysozyme activity of infected tilapia fed SF60/ZZ40, BP90/SF10 and BP50/SF50 combinations of extract did not show a significant increase (
P<0.05) at weeks 2 and 4 in the treatment test. However, starting from weeks 2–4, the addition of SF50/ZZ50 combination extract in the diet of fish resulted in significantly better lysozyme activity (
Figure 5). Meanwhile, in the prevention test at weeks 2 and 4, the lysozyme activity of tilapia fed SF50/ZZ50 was significantly higher (
P<0.05) (
Figure 6) than in other combinations.
Figure 5.
Lysozyme activity (μg mL
-1) of Tilapia (
Oreochromis niloticus) fed different extract combination in treatment trials.
BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg kg
-1 feed. * = significantly different between week. Different letter above the bars in each week showed significantly different at
P<0.05.
Figure 6.
Lysozyme activity (μg mL
-1) of Tilapia (
Oreochromis niloticus) fed different extract combination in prevention trials.
BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. Infected-fish fed various combination and ratio of extract, namely: A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg kg
-1 feed. * = significantly different between week. Different letter above the bars in each week showed significantly different at
P<0.05.
Lysozyme activity (μg mL
-1) of Tilapia (
Oreochromis niloticus) fed different extract combination in treatment trials.
BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg kg
-1 feed. * = significantly different between week. Different letter above the bars in each week showed significantly different at
P<0.05.
Lysozyme activity (μg mL
-1) of Tilapia (
Oreochromis niloticus) fed different extract combination in prevention trials.
BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. Infected-fish fed various combination and ratio of extract, namely: A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg kg
-1 feed. * = significantly different between week. Different letter above the bars in each week showed significantly different at
P<0.05.
TPC
The overall combination of extracts administered to treat and prevent infection by
A. hydrophila and
P. fluorescens may decrease the number of bacteria in the fish body until the 4
th week of observation (
Table 2). The bacterial density, in both the treatment and prevention trials was lower than in the control. Total bacteria
of A. hydrophila and
P. fluorescens in tilapia fish fed combination extract in the treatment trial decreased from weeks 2–4. Further, the lowest bacterial density in tilapia was obtained from the fish fed SF50/ZZ50 combination extracts in their diet, which was also significantly different (
P<0.05) compared to the control.
Table 2.
Total Plate Count (10
6 CFU/mL) in Tilapia (
Oreochromis niloticus) fed different extract combination in treatment and prevention trials.
Trials
Groups
Week
2
4
Treatment
A
17.4±5
[a]
10.86±10
[c]
B
22.4±15
[a]
3.05 ±10
[d]
C
55±10
[b]
16±15
[c]
D
47±10
[b]
4.82±10
[d]
E
42.85±15
[b]
30.9±5
[b]
Prevention
A
7.8±15
[a]
5.71±15
[a]
B
9.16±5
[b]
3.15±10
[d]
C
6.65±10
[a]
4.6±5
[d]
D
11.15±11
[c]
8.27±10
[a]
E
12.68±11
[c]
15.3±10
[c]
Note: Mean±standard deviation followed by different superscript letters (a,b,c,d) in the same column in each treatment or prevention trial showed significantly different at
P<0.05. A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg kg
-1 feed. BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. CFU = Colony forming unit. In treatment and prevention trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence.
Note: Mean±standard deviation followed by different superscript letters (a,b,c,d) in the same column in each treatment or prevention trial showed significantly different at
P<0.05. A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg kg
-1 feed. BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. CFU = Colony forming unit. In treatment and prevention trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence.
Survival rate
The administration of extract with different combinations on tilapia injected with
A. hydrophila and
P. fluorescens bacteria increased the SR and RPS when compared to those not given the extracts (
Table 3 and
Table 4). The percentage of survival of tilapia in treatment and prevention trials with combination extracts of SF 50/ZZ 50 had the highest SR compared to the other combinations of extract.
Table 3.
Survival rate (%) of Tilapia (
Oreochromis niloticus) fed different extract combination in treatment and prevention trials.
Trials
Groups
Week
4
Treatment
SF 60/ZZ 40
76.67
[a]
SF 50/ZZ 50
87.00
[a]
BP 90/SF 10
76.67,30
[a]
BP 50/SF 50
83.33.00
[a]
No extract
33.00
[b]
Prevention
SF 60/ZZ 40
86.67
[a]
SF 50/ZZ 50
90
[b]
BP 90/SF 10
80
[b]
BP 50/SF 50
76.67
[a]
No extract
27
[c]
Note: Mean±standard deviation followed by different superscript letters (a,b,c) in the same column in each treatment or prevention trial showed significantly different at
P<0.05. A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg per kg feed. BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment and prevention trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence.
Table 4.
Relative Percent Survival (RPS) of Tilapia (
Oreochromis niloticus) fed different extract combination in treatment and prevention trials.
Trials
Groups
Week
4
Treatment
SF 60/ZZ 40
65
[a]
SF 50/ZZ 50
80
[b]
BP 90/SF 10
65
[a]
BP 50/SF 50
75
[b]
No extract
Prevention
SF 60/ZZ 40
82
[a]
SF 50/ZZ 50
86
[b]
BP 90/SF 10
73
[a]
BP 50/SF 50
68
[a]
No extract
Note: Mean±standard deviation followed by different superscript letters (a,b,c) in the same column in each treatment or prevention trial showed significantly different at
P<0.05. A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in ml per kg feed. BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment and prevention trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. Extract ratio is in mg kg
-1 feed.
Note: Mean±standard deviation followed by different superscript letters (a,b,c) in the same column in each treatment or prevention trial showed significantly different at
P<0.05. A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in mg per kg feed. BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment and prevention trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence.Note: Mean±standard deviation followed by different superscript letters (a,b,c) in the same column in each treatment or prevention trial showed significantly different at
P<0.05. A = SF60/ZZ40, B = SF50/ZZ50, C = BP90/SF10, D = BP50/SF50, E = No extract addition. Extract ratio is in ml per kg feed. BP =
Boesenbergia pandurata), SF =
Solanum ferox, and ZZ =
Zingiber Zerumbet. In treatment and prevention trials, fish was infected with
Aeromonas hydrophila and
Pseudomonas fluorescence. Extract ratio is in mg kg
-1 feed.
Discussion
The number of infectious diseases caused by pathogenic bacteria such as
A. hydrophila have become a pivotal concern in fish culture, causing high economic losses owing to high mortality rates
[5]. The use of plant-based extracts as immunodulators has been applied to increase survival and immune system of fish to prevent or cure bacterial pathogen. Several plant extracts that contain active phytochemicals have been found and used as supplements in the feed of fish
[26–
29].The current study found that the WBC of tilapia infected by both bacteria in the prevention and treatment trials increased significantly (
P<0.05), while the RBC of tilapia infected by both bacteria in the prevention and treatment trials decreased significantly (
P<0.05). This result is similar to those of a previous study, which stated that the WBC increased in order to tackle the infection, while the RBC was decreased in tilapia infected with
Streptococcus agalactiae bacteria
[30],
S. iniae
[10],
A. hydrophila and
Pseudomonas sp.
[7]. In contrast, tilapia fed with a combination of extracts SF60/ZZ40 showed a similar RBC value both in treatment and prevention trials. In addition, tilapia fed SF50/ZZ50 in treatment trial resulted the highest RBC at the end of the trial. The Hb and Htc values were unchanged during the first week of all treatments including control; the decrease in Htc and Hb values occurred in controls without extract from weeks 2–4 post-infection in the prevention and treatment trials. This result indicated that the combined administration of the extracts was capable of improving the performance of the fish immune system by producing more WBC, thus making the fish more able to suppress the growth of bacteria in the body.RBC, WBC, Hb and Htc can be used as an indicator of the blood profile in fish with respect to the innate immune defence and regulation of immunological function
[31]. WBC are particularly responsible for providing protection or resistance to disorders caused by infectious pathogens and non-infectious factors (nutrition, temperature and handling)
[32]. Total value of WBC also describes the health status and immune system of the fish. In addition to haematological statues, the Hb content decreases due to RBC swelling and poor Hb mobilization of the spleen and other haematopoesis organs
[33].Besides blood profiles, the phagocytic index, respiratory burst and lysozyme activity are good indicators for immunological status of fish during infection periods. The present results revealed that infected fish treated with a compound extract of SF50/ZZ50 showed the highest IP and increased from weeks 2–4 post-injection. These results are in line with the results of a previous study, which found that fish treated with immunostimulants usually show enhanced phagocytic cell activities
[34]. Fish have several types of phagocytic leukocytes, which are part of WBC, in the peritoneal cavity, and various tissues. The phagocytic index is also associated with the production of oxygen free radicals by using respiratory bursts, which are important events in bactericidal pathways in fish
[35,
36].According to Isnansetyo
et al.
[37], the phagocytic index is an important indicator of the enhancement of the immune system, which is showed by increasing the function of phagocytes. In addition, the increasing of phagocytic activity is affected by a complement that enhances the frequency of antigen-antibody, attaches to the receptor of phagocytosis cells, and stimulates phagocytes cells to make a forward migration to the site of infection Further, the forward migration to the site of infection has a close relationship with phagocytosis index. In addition, Secombes and Olivier
[23] revealed that the release of superoxide anions, hydrogen peroxide and hypochlorous acid into the phagosome and extracellular space during the respiratory burst can be also considered as the pivotal mechanisms involved in the bactericidal activity of macrophages.Total lysozyme level is a tool to measure the humoral component of the non-specific defence mechanism (innate immunity), which can be used to detect infections or injections of foreign material, including bacteria
[38–
40]. The present findings determined that tilapia fed SF 50/ZZ 50 had significantly higher (
P<0.05) lysozyme activity. This finding is in line with past research, stating that the lysozyme activity of Jian carp (
Cyprinus carpio var. Jian)
[41] and large yellow croaker,
Pseudosciaena crocea
[41,
42] were increased after being fed with traditional Chinese medicine formulated from Astragalus root (
Radix astragalin seu Heydsari) and Chinese Angelica root (
R. angelicae Sinenesis).Past research stated that the increasing survival rate and relative percent survival related to the increasing immune function of the fish which is affected by plant extract supplementation. Plant extracts containing important phytochemicals may increase monocytes, granulocytes, macrophages and neutrophils in fish, improving non-specific immune responses
[5]. Moreover, activated macrophages and neutrophils in the blood of fish also increase the number of reactive oxygen and nitrogen intermediates (ROIs and RNIs), which are toxic to bacteria
[22].
Conclusion
A combination of plant extracts was found to affect the health status of tilapia when compared with control. A combination of extracts of SF and ZZ (50:50 mg/kg of feed) provides the optimum protection against bacterial infections of
A. hydrophila and
P. fluorescens in both prevention and treatment assays.
Data availability
Raw data for Tables and Figures can be accessed on OSF, DOI:
https://doi.org/10.17605/OSF.IO/A42JB
[43].Data are available under the terms of the
Creative Commons Zero “No rights reserved” data waiver (CC0 1.0 Public domain dedication).There is a significant weakness in the part of M&M of this article but this can be corrected after which its scientific value could surely be elevated.Some statistical re- evaluation of the data would also be useful.Please see my annotated copy of the article
which includes additional corrections and suggestions.I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.The authors already addressed almost all reviewer commands, and overall the manuscript quality is improved significantly. However, there is one parameter that should be clarified:It is still confusing between Phagocytic activity (PA) and Phagocytic Index (PI). The unit for PA is percent (%) and the unit of PI is cells or particles/Phagocyte. I think, the authors observed PA, instead of PI as the unit is %. Please replace the PI to PA.I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.I am happy to note that the manuscript has now improved significantly from the original submission. The corrections made by the authors are satisfactory and I can now recommend this paper for indexing.I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.This article presented the finding of Indonesian herbal extracts for preventing and treating fish diseases. This article might be indexed after several major issues are addressed:Are
Boesenbergia pandurata (BP),
Solanum ferox (SF) and
Zingiber Zerumbet (ZZ) typical plants in Borneo? Are the plants not found in the other parts of Indonesia? If yes, please replace the "Borneo" with "Indonesia" in the title and throughout the article.Write one sentence of background in the Abstract.Describe systematically in the Abstract: how to prepare the extracts, design experiment, feed preparation, infection, data collecting (hematology, non-specific immune etc.) and data analysis.Write the exact concentration for the extract in mg/kg feed instead of ml/kg. Using units of ml/kg feed is not appropriate as the exact concentrations are not known.Write systematically the results in the Abstract as described in the Methods.The units are written inconsistently: format (.../...., .... per ...., .... ....
-1 ).“Antibody titre” is a term to evaluate the effect of vaccines. To evaluate the effect of immunostimulants, we should use the term "Natural Agglutination" as we are not evaluating the specific antibody. No data are presented for Antibody titre/Natural Agglutination, even though this parameter is described in the Methods.The authors are confused by the terms of phagocytic activity and phagocytic index. Phagocytic index is not described before either in the Abstract or Materials and Methods. However, the authors describe phagocytic activity in Materials and Methods. Phagocytic index and phagocytic activity are two different parameters. Please refer to some of the recommended references. Add deviation standard for each bar in all graphs.Add the notation in each bar of all graphs and values in tables to show insignificant or significant difference based on DMRT test results.Discussion: please interpret properly and add additional explanation about why the extracts affect the immune system of fish and increase the SR and RPS. Describe the possible constituents in the extracts by citing the previous publications.Add these references in the Introduction, Materials and Methods, and Discussion: Yudiati
et al. (2016
[1]), Isnansetyo
et al. (2016
[2]) and Isnansetyo
et al. (2015
[3]).Some grammatical errors were found.I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.Dear Dr. Alim Isnansetyo,Thank you for your valuable comment on our article. We have added some important information based on your comment and suggestions. We really appreciate it. For further details of our responses to your comment, please download the details of our responses from this link below:https://osf.io/qwy8z/download [direct download link]After checking the research article “Borneo herbal plant extracts as a natural medication for prophylaxis and treatment of Aeromonas hydrophila and Pseudomonas fluorescensinfection in tilapia (Oreochromis niloticus)” by Dr. Rudy
et al., I reached the following suggestions to be made for the article’s acceptance:The overall structure of the manuscript is satisfactory, though some changes are recommended.In the introduction the mechanism of action of plant extracts and its medical importance could have been added.The authors didn’t mention the composition of feed.There is a possibility of residual ethanol in the sample. How can you conclude the results with this concern?The nature and source of chemicals (Materials) used in this experiment are not mentioned.Footnotes can be much clearer and the legends used in the figure should be mentioned properly. Also, in some graphs standard deviation is missing.Give enough information about the figures in figure legends.The Discussion part can be much stronger.In conclusion, the content of the manuscript has value for indexing. The mentioned suggestions can be considered and resubmitted.I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.Dear Dr. Vishnu Venugopal,First of all, we would like to say thank you for your valuable review and comment. We have revised our article according to your review. We have also made some responses to your review - for the details of our responses, please see the link below:http://osf.io/vzsqe/download [direct download link]
Authors: Farida Nurzhanova; Gaisa Absatirov; Bekzhasar Sidikhov; Alexander Sidorchuk; Nurbek Ginayatov; Kenzhebek Murzabaev Journal: Vet World Date: 2021-03-02